Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kulkarni Samarth
Chief Executive Officer at CRISPR Therapeutics. Filing since 19 Apr 2017.
CIK 0001682019
Company
Date
Role
Action
Shares
Amount
Of holding
CRSP
CRISPR Therapeutics AG
23 Mar 2026
Chief Executive Officer
Sold at will
10,020
$468.74K
3.8%
CRSP
CRISPR Therapeutics AG
16 Mar 2026
Chief Executive Officer
Sold at will
10,349
$499.44K
4.0%
CRSP
CRISPR Therapeutics AG
11 Mar 2026
Chief Executive Officer
Sold at will
9,798
$517.33K
4.0%
CRSP
CRISPR Therapeutics AG
19 Feb 2026
Chief Executive Officer
Sold at will
6,967
$366.32K
3.0%
CRSP
CRISPR Therapeutics AG
22 Jan 2026
Chief Executive Officer
Sold on a plan
60,000
$3.61M
30.9%
CRSP
CRISPR Therapeutics AG
20 Jan 2026
Chief Executive Officer
Sold on a plan
30,000
$1.55M
13.4%
CRSP
CRISPR Therapeutics AG
17 Oct 2025
Chief Executive Officer
Sold at will
50,895
$3.46M
16.7%
CRSP
CRISPR Therapeutics AG
14 Oct 2025
Chief Executive Officer
Sold at will
4,242
$282.52K
2.0%
CRSP
CRISPR Therapeutics AG
18 Aug 2025
Chief Executive Officer
Sold at will
13,081
$760.66K
5.9%
CRSP
CRISPR Therapeutics AG
21 Mar 2025
Chief Executive Officer
Sold at will
10,031
$413.58K
4.9%
CRSP
CRISPR Therapeutics AG
12 Mar 2025
Chief Executive Officer
Sold at will
4,462
$193.29K
2.3%
CRSP
CRISPR Therapeutics AG
11 Mar 2025
Chief Executive Officer
Sold at will
9,973
$423.05K
5.2%
CRSP
CRISPR Therapeutics AG
19 Feb 2025
Chief Executive Officer
Sold on a plan
25,288
$1.38M
12.8%
CRSP
CRISPR Therapeutics AG
18 Feb 2025
Chief Executive Officer
Sold on a plan
11,640
$640.78K
5.6%
CRSP
CRISPR Therapeutics AG
2 Dec 2024
Chief Executive Officer
Sold on a plan
15,000
$826.56K
7.6%
CRSP
CRISPR Therapeutics AG
11 Nov 2024
Chief Executive Officer
Sold on a plan
30,000
$1.67M
13.2%
CRSP
CRISPR Therapeutics AG
14 Oct 2024
Chief Executive Officer
Sold at will
4,293
$198.68K
1.9%
CRSP
CRISPR Therapeutics AG
15 Apr 2024
Chief Executive Officer
Sold on a plan
19,582
$1.17M
8.6%
CRSP
CRISPR Therapeutics AG
15 Mar 2024
Chief Executive Officer
Sold on a plan
20,000
$1.45M
8.8%
CRSP
CRISPR Therapeutics AG
12 Mar 2024
Chief Executive Officer
Sold at will
4,583
$341.16K
2.2%
CRSP
CRISPR Therapeutics AG
11 Mar 2024
Chief Executive Officer
Sold at will
9,802
$767.10K
4.6%
CRSP
CRISPR Therapeutics AG
20 Feb 2024
Chief Executive Officer
Sold at will
6,370
$507.50K
3.2%
CRSP
CRISPR Therapeutics AG
15 Feb 2024
Chief Executive Officer
Sold on a plan
20,000
$1.61M
9.6%
CRSP
CRISPR Therapeutics AG
29 Jan 2024
Chief Executive Officer
Sold on a plan
50,000
$3.03M
21.1%
CRSP
CRISPR Therapeutics AG
16 Jan 2024
Chief Executive Officer
Sold on a plan
20,000
$1.25M
9.6%
CRSP
CRISPR Therapeutics AG
30 May 2023
Chief Executive Officer
Sold on a plan
25,000
$1.62M
6.1%
CRSP
CRISPR Therapeutics AG
25 Apr 2023
Chief Executive Officer
Sold on a plan
25,000
$1.27M
6.1%
CRSP
CRISPR Therapeutics AG
29 Mar 2023
Chief Executive Officer
Sold at will
25,000
$1.11M
6.1%
CRSP
CRISPR Therapeutics AG
27 Feb 2023
Chief Executive Officer
Sold, plan not stated
25,000
$1.21M
6.2%
CRSP
CRISPR Therapeutics AG
27 Jan 2023
Chief Executive Officer
Sold, plan not stated
25,000
$1.29M
6.3%
CRSP
CRISPR Therapeutics AG
28 Dec 2022
Chief Executive Officer
Sold, plan not stated
25,000
$1.02M
6.3%
CRSP
CRISPR Therapeutics AG
28 Nov 2022
Chief Executive Officer
Sold, plan not stated
25,000
$1.35M
7.9%
CRSP
CRISPR Therapeutics AG
26 Oct 2022
Chief Executive Officer
Sold, plan not stated
25,000
$1.37M
7.9%
CRSP
CRISPR Therapeutics AG
28 Sep 2022
Chief Executive Officer
Sold, plan not stated
25,000
$1.62M
7.9%
CRSP
CRISPR Therapeutics AG
29 Aug 2022
Chief Executive Officer
Sold, plan not stated
25,000
$1.67M
7.9%
CRSP
CRISPR Therapeutics AG
27 Jul 2022
Chief Executive Officer
Sold, plan not stated
25,000
$1.90M
7.9%
CRSP
CRISPR Therapeutics AG
29 Jun 2022
Chief Executive Officer
Sold, plan not stated
25,000
$1.54M
7.9%
CRSP
CRISPR Therapeutics AG
5 Aug 2021
Chief Executive Officer
Sold, plan not stated
28,500
$3.68M
13.2%
CRSP
CRISPR Therapeutics AG
4 Aug 2021
Chief Executive Officer
Sold, plan not stated
1,500
$187.53K
0.8%
CRSP
CRISPR Therapeutics AG
15 Jun 2021
Chief Executive Officer
Sold, plan not stated
30,000
$3.79M
13.8%
CRSP
CRISPR Therapeutics AG
15 Jan 2021
Chief Executive Officer
Sold, plan not stated
20,000
$4.27M
9.9%
CRSP
CRISPR Therapeutics AG
10 Dec 2020
Chief Executive Officer
Sold, plan not stated
20,000
$2.85M
10.6%
CRSP
CRISPR Therapeutics AG
1 Jun 2020
Chief Executive Officer
Sold, plan not stated
17,275
$1.12M
9.1%
CRSP
CRISPR Therapeutics AG
20 May 2020
Chief Executive Officer
Sold, plan not stated
10,693
$698.04K
5.9%
CRSP
CRISPR Therapeutics AG
19 May 2020
Chief Executive Officer
Sold, plan not stated
4,307
$280.64K
2.4%
CRSP
CRISPR Therapeutics AG
17 Jun 2019
Chief Executive Officer
Sold, plan not stated
20,000
$920.00K
10.8%
CRSP
CRISPR Therapeutics AG
29 Apr 2019
Chief Executive Officer
Sold, plan not stated
20,000
$840.60K
10.7%
CRSP
CRISPR Therapeutics AG
1 Jun 2018
Chief Executive Officer
Sold, plan not stated
15,000
$1.04M
9.2%
CRSP
CRISPR Therapeutics AG
30 Aug 2017
Chief Business Officer
Sold, plan not stated
4,000
$80.00K
3.6%
CRSP
CRISPR Therapeutics AG
28 Aug 2017
Chief Business Officer
Sold, plan not stated
23,154
$465.16K
17.3%
CRSP
CRISPR Therapeutics AG
27 Apr 2017
Chief Business Officer
Sold, plan not stated
2,206
$37.02K
1.6%
CRSP
CRISPR Therapeutics AG
26 Apr 2017
Chief Business Officer
Sold, plan not stated
3,275
$54.82K
2.4%
CRSP
CRISPR Therapeutics AG
25 Apr 2017
Chief Business Officer
Sold, plan not stated
5,115
$86.29K
3.7%
CRSP
CRISPR Therapeutics AG
24 Apr 2017
Chief Business Officer
Sold, plan not stated
3,500
$57.62K
2.5%
CRSP
CRISPR Therapeutics AG
21 Apr 2017
Chief Business Officer
Sold, plan not stated
3,000
$51.03K
2.2%
CRSP
CRISPR Therapeutics AG
20 Apr 2017
Chief Business Officer
Sold, plan not stated
2,800
$48.62K
2.0%
CRSP
CRISPR Therapeutics AG
19 Apr 2017
Chief Business Officer
Sold, plan not stated
7,258
$129.75K
5.1%
57 decisions on file.
